Redmond Asset Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$42.3K Sell
2023
Q4
$24.9K Sell
2023
Q3
$29.2K Buy
2023
Q2
$75.7K Buy
2023
Q1
$82.7K Hold
2022
Q4
$62.9K Buy
2022
Q3
$111K Sell
2022
Q2
$91K Hold
2022
Q1
$182K Buy